Literature DB >> 791549

Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions.

G Bjune, R S Barnetson, D S Ridley, G Kronvall.   

Abstract

Lymphocyte transformation tests (LTT) using 'whole washed" and 'sonicated" preparations of Mycobacterium leprae (M. leprae) as antigen were studied in eighty-one patients with borderline leprosy. The results were correlated with the histological and the clinical pictures. There was a good correlation with the histological spectrum, LTT responses generally being higher in the borderline tuberculoid leprosy patients and lower in the borderline lepromatous. However, considerable variation was noted in each group of the borderline leprosy spectrum, and it was found that this was due in part to the degree of inflammation in the skin. Thus those with 'inflamed" skin lesions had higher responses than those with 'silent" lesions, and even those with borderline lepromatous leprosy with inflamed lesions had higher responses than those with borderline tuberculoid leprosy whose lesions were silent. Those who had reversal reactions, where inflammation is very marked, had very high LTT responses which fell with treatment of the reaction with steroids. It thus appears that the LTT in leprosy is influenced by the occurrence of hypersensitivity reactions as well as by the patient's ability to resist bacillary multiplication.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 791549      PMCID: PMC1541375     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Transformation of two borderline-lepromatous leprosy cases to tuberculoid, with healing.

Authors:  J M FERNANDEZ; E A CARBONI; R A MERCAU; A SERIAL
Journal:  Int J Lepr       Date:  1962 Jul-Sep

2.  Histological classification and the immunological spectrum of leprosy.

Authors:  D S Ridley
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

3.  Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.

Authors:  B Myrvang; T Godal; D S Ridley; S S Fröland; Y K Song
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

4.  Delayed-type hypersensitivity and immunity against aerogenic tuberculosis in guinea pigs.

Authors:  Z Reggiardo; G Middlebrook
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

5.  Temporary suppression of lymphocyte transformation after tuberculin skin testing.

Authors:  K Thestrup-Pedersen
Journal:  Immunology       Date:  1974-12       Impact factor: 7.397

6.  Significance of variations within the lepromatous group.

Authors:  D S Ridley; M F Waters
Journal:  Lepr Rev       Date:  1969-07       Impact factor: 0.537

7.  The use of the voluntary muscle test in leprosy neuritis.

Authors:  C S Goodwin
Journal:  Lepr Rev       Date:  1968-10       Impact factor: 0.537

8.  In vitro lymphocyte response to purified protein derivative, BCG and Mycobacterium leprae in a population not exposed to leprosy.

Authors:  O Closs
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

Review 9.  Relation between delayed hypersensitivity and immunity in tuberculosis.

Authors:  G P Youmans
Journal:  Am Rev Respir Dis       Date:  1975-02

10.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep
View more
  39 in total

Review 1.  T cell and cytokine patterns in leprosy skin lesions.

Authors:  P A Sieling; R L Modlin
Journal:  Springer Semin Immunopathol       Date:  1992

2.  [Immune reconstitution syndrome].

Authors:  D Meyer-Olson; D Ernst; M Stoll
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

Review 3.  Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.

Authors:  Roberta Olmo Pinheiro; Jorgenilce de Souza Salles; Euzenir Nunes Sarno; Elizabeth Pereira Sampaio
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

4.  Tuberculous anergic sera or purified protein derivative treatment induces modification in lymphocyte transformation of cells from patients with tuberculosis.

Authors:  H Mejia-López; O Vaca-García; J M Cristerna-Aguirre; A Cruz-Chávez; M Selman-Lama; M L Taylor
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

5.  Humoral immunity in leprosy: immunoglobulin G and M antibody responses to Mycobacterium leprae in relation to various disease patterns.

Authors:  J Touw; E M Langendijk; G L Stoner; A Belehu
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy.

Authors:  Megan S Inkeles; Rosane Mb Teles; Delila Pouldar; Priscila R Andrade; Cressida A Madigan; David Lopez; Mike Ambrose; Mahdad Noursadeghi; Euzenir N Sarno; Thomas H Rea; Maria T Ochoa; M Luisa Iruela-Arispe; William R Swindell; Tom Hm Ottenhoff; Annemieke Geluk; Barry R Bloom; Matteo Pellegrini; Robert L Modlin
Journal:  JCI Insight       Date:  2016-09-22

7.  Late-stage cutaneous leishmaniasis: immunopathology of tuberculoid lesions in skin and lymph nodes.

Authors:  D S Ridley; M J Ridley
Journal:  Br J Exp Pathol       Date:  1984-06

8.  Suppression of the antibody response to sulfolipids in leprosy patients by 4,4'-diaminodiphenyl sulfone (DDS).

Authors:  U Malik; G K Khuller; B Kumar
Journal:  Antonie Van Leeuwenhoek       Date:  1983-12       Impact factor: 2.271

9.  Tumor necrosis factor production in patients with leprosy.

Authors:  P F Barnes; D Chatterjee; P J Brennan; T H Rea; R L Modlin
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Divergence of macrophage phagocytic and antimicrobial programs in leprosy.

Authors:  Dennis Montoya; Daniel Cruz; Rosane M B Teles; Delphine J Lee; Maria Teresa Ochoa; Stephan R Krutzik; Rene Chun; Mirjam Schenk; Xiaoran Zhang; Benjamin G Ferguson; Anne E Burdick; Euzenir N Sarno; Thomas H Rea; Martin Hewison; John S Adams; Genhong Cheng; Robert L Modlin
Journal:  Cell Host Microbe       Date:  2009-10-22       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.